APA

Chiu C., Yeh T., Lu C., Huang Y., Cheng Y., Huang Y., Weng Y., Liu Y., Lai S., Chen Y., Chen Y., Chen C., Chen H., Lin Y. & Wang H. (2017). PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway. : Oncotarget.

Chicago

Chiu Ching-Chi, Yeh Tu-Hsueh, Lu Chin-Song, Huang Yin-Cheng, Cheng Yi-Chuan, Huang Ying-Zu, Weng Yi-Hsin, Liu Yu-Chuan, Lai Szu-Chia, Chen Ying-Ling, Chen Yu-Jie, Chen Chao-Lang, Chen Hsin-Yi, Lin Yan-Wei and Wang Hung-Li. 2017. PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway. : Oncotarget.

Harvard

Chiu C., Yeh T., Lu C., Huang Y., Cheng Y., Huang Y., Weng Y., Liu Y., Lai S., Chen Y., Chen Y., Chen C., Chen H., Lin Y. and Wang H. (2017). PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway. : Oncotarget.

MLA

Chiu Ching-Chi, Yeh Tu-Hsueh, Lu Chin-Song, Huang Yin-Cheng, Cheng Yi-Chuan, Huang Ying-Zu, Weng Yi-Hsin, Liu Yu-Chuan, Lai Szu-Chia, Chen Ying-Ling, Chen Yu-Jie, Chen Chao-Lang, Chen Hsin-Yi, Lin Yan-Wei and Wang Hung-Li. PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway. : Oncotarget. 2017.